Increase in brain tumors is not attributed to mobile phone use
the ONA take:
New research from the University of Auckland found that risk of brain cancer is not increased by mobile phone use. Concerns have been raised about whether use of mobile phones can increase the incidence of brain cancers.
Previous studies from around the world reported findings that showed no risk or a slightly increased risk, with some studies suggesting a substantial risk.
The New Zealand team examined the frequency of brain cancers in total and in subtypes highlighted in other studies, using data from the New Zealand cancer registry.
These investigators found no general increase. They did see, however, was a decrease of approximately 1% per year in people 10 to 69 years. Based on their findings, they report previous findings of large increases in risk are likely to be incorrect.
However, they concede that a study of this type cannot exclude a small risk, or one limited to certain subtypes of cancers, or a risk arising after more than 15 years of phone use.
The research team cannot explain the decrease in brain cancers in New Zealand. An increase in some types of brain cancer among people 70 years and older—in New Zealand and other countries—may be related to improved diagnosis.
Brain cancer is not increased by mobile phone use.
Sign Up for Free e-newsletters
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Patients and Caregivers Worry About Cost of Cancer Care
- Integrative Medicine in Childhood Cancer: Practices That Can Help Pediatric Patients
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Seeking an Explanation for the Lack of Research Focused in Pediatric Oncology Therapeutics
- Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia
- G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher
- Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE
- The Effect of Intravenous Hydration Strategy on Plasma Methotrexate Clearance During Intravenous High-dose Methotrexate Administration in Pediatric Oncology Patients
- Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|